Mu-heavy chain disease: presentation as a benign monoclonal gammopathy
- PMID: 1566748
- DOI: 10.1002/ajh.2830400112
Mu-heavy chain disease: presentation as a benign monoclonal gammopathy
Abstract
mu-Heavy chain disease (HCD) is a rare monoclonal lymphoid disorder characterized by the failure to assemble a complete IgM immunoglobulin. The mu-heavy chains analyzed to date revealed absence of the variable region and a shortened constant domain. We report the first case of mu-HCD presenting as a benign monoclonal gammopathy. The literature on the 27 reported mu-HCD cases is reviewed, and important clinical and laboratory findings are discussed. The ages of the patients ranged from 15 to 80 years (median, 57.5 years). Twenty-two of 27 patients had an associated lymphoplasma cell proliferative disorder. A monoclonal spike on routine serum protein electrophoresis was found in only 8 of 19 patients. Fourteen of 22 patients had Bence Jones proteinuria, but mu-HCD protein was reported in the urine of only two patients. The survival ranged from less than 1 month to 11 years (median, 24 months).
Similar articles
-
Heavy chain diseases.Best Pract Res Clin Haematol. 2005;18(4):729-46. doi: 10.1016/j.beha.2005.01.029. Best Pract Res Clin Haematol. 2005. PMID: 16026747 Review.
-
Mu-heavy chain disease associated with systemic amyloidosis.Hematology. 2004 Apr;9(2):135-7. doi: 10.1080/10245330410001671561. Hematology. 2004. PMID: 15203869
-
[Heavy chain disease].Nihon Rinsho. 1995 Mar;53(3):730-5. Nihon Rinsho. 1995. PMID: 7699914 Review. Japanese.
-
Gamma-heavy chain disease: review of 23 cases.Medicine (Baltimore). 2003 Jul;82(4):236-50. doi: 10.1097/01.md.0000085058.63483.7f. Medicine (Baltimore). 2003. PMID: 12861101
-
Capillary immunotyping electrophoresis and high resolution two-dimensional electrophoresis for the detection of mu-heavy chain disease.Clin Chim Acta. 2008 Mar;389(1-2):171-3. doi: 10.1016/j.cca.2007.10.035. Epub 2007 Nov 6. Clin Chim Acta. 2008. PMID: 18036562
Cited by
-
Two Cases of Heavy Chain MGUS.Case Rep Oncol Med. 2016;2016:8749153. doi: 10.1155/2016/8749153. Epub 2016 Apr 26. Case Rep Oncol Med. 2016. PMID: 27213064 Free PMC article.
-
Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.Int J Hematol. 2004 Feb;79(2):174-7. doi: 10.1532/ijh97.03053. Int J Hematol. 2004. PMID: 15005347 Review.
-
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.Int J Mol Sci. 2022 Apr 30;23(9):5009. doi: 10.3390/ijms23095009. Int J Mol Sci. 2022. PMID: 35563400 Free PMC article. Review.
-
Heavy chain disease.Curr Treat Options Oncol. 2002 Jun;3(3):247-54. doi: 10.1007/s11864-002-0014-3. Curr Treat Options Oncol. 2002. PMID: 12057070 Review.
-
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018011. doi: 10.4084/MJHID.2018.011. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 29326807 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials